Fernando Muzzio, Principal Consultant, Acumen BioPharma, LLC to Speak at Patent Protection for Pharma and Biotechnology in 2020 LIVE Webcast
The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Fernando Muzzio, Principal Consultant, Acumen BioPharma, LLC will speak at the Knowledge Group’s webcast entitled: “Patent Protection for Pharma and Biotechnology in 2020 LIVE Webcast.”
- (1888PressRelease) April 20, 2020 - This event is scheduled for Thursday, April 23, 2020 from 3:00PM to 4:30PM ET.
For further details, please visit:
https://www.theknowledgegroup.org/webcasts/pharma-and-biotechnology-in-2020/
About Fernando Muzzio
Dr. Fernando J. Muzzio is a distinguished Professor of Chemical and Biochemical Engineering at Rutgers University. For the last 28 years, pharmaceutical product and process design has been his main research and educational focus, with emphasis on continuous manufacturing, powder mixing, powder flow, segregation, compression, mixing and flow of liquids and suspensions, capsule filling, tablet dissolution, and tablet coating. He is the author of over 300 peer-reviewed scientific articles and book chapters. He is a frequent participant at FDA events, and in 2010-2014 he was appointed a voting member of the FDA committee on Pharmaceutical Sciences and clinical pharmacology.
Dr. Muzzio has been an expert witness in numerous IP litigation cases, with a special focus on formulation and manufacturing processes for solid dose, inhalable, and suspension products.
About Acumen BioPharma, LLC
Acumen BioPharma provides expert witness consulting and laboratory services to law firms engaged in intellectual property and antitrust litigation related to the pharmaceutical industry. Our expertise includes all aspects of manufacturing technology, regulatory, supply chain and commercial operations involved for branded and generics pharmaceuticals and biopharmaceutical products. Acumen BioPharma’s subsidiary registered as Integra Continuous Manufacturing Systems (www.integracms-pharma.com) is dedicated to consulting services in advance manufacturing technology to assist clients in the design and implementation of continuous manufacturing lines for pharmaceutical products.
Abstract
Pharmaceutical and biotechnology patents have increased aggressively in recent years. Consequently, this upward trend has posed a greater risk for the U.S. pharma patents. Political and economic troubles such as claims of patent evergreening abuse have also added complexity on existing challenges.
As biopharma innovators face this troubled landscape, effective IP protection strategies have become more imperative. Current and future plans must be carefully weaved to properly address legal challenges.
In this LIVE Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide the audience with an in-depth analysis of the fundamentals as well as recent developments in pharma and biotechnology patent. Speakers will also present helpful tips on how companies and patent owners can strengthen their strategies to overcome significant hurdles.
Key topics include:
• Trends and Developments in U.S. Pharma and Biotechnology Patents
• Current and Emerging Challenges Faced by Patent Owners
• Notable Cases
• Best Practices and Helpful Tips
• Outlook
About The Knowledge Group
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam